
Sign up to save your podcasts
Or


Sally Mossman, VP, Vaccines R&D and Head Discovery Performance Unit at GSK, joins BioTalk to discuss their Rockville location, why the BioHealth Capital Region is right for the GSK, and their role in the development of a COVID-19 Vaccine.
By BioHealth Innovation, Inc. (BHI)4.7
1111 ratings
Sally Mossman, VP, Vaccines R&D and Head Discovery Performance Unit at GSK, joins BioTalk to discuss their Rockville location, why the BioHealth Capital Region is right for the GSK, and their role in the development of a COVID-19 Vaccine.

10,182 Listeners